Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 329-331

  Carrano, Anna ^a   Hoozemans, Jeroen J M ^a   Van Der Vies, Saskia M ^a   Van Horssen, Jack ^a   De Vries, Helga E ^a   Rozemuller, Annemieke J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Blood brain barrier; Cerebral amyloid angiopathy; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; CLAUDIN 5; FIBRINOGEN; OCCLUDIN; PROTEIN ZO1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ARTICLE; AUTOPSY; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN TISSUE; CADAVER; CAPILLARY CEREBRAL AMYLOID ANGIOPATHY; CAPILLARY ENDOTHELIUM; CLINICAL ARTICLE; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROGLIA; MULTICENTER STUDY; NEUROINFLAMMATION; NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VASCULAR AMYLOIDOSIS;

AMYLOID BETA-PEPTIDES; BLOOD PROTEINS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; CEREBRAL AMYLOID ANGIOPATHY; CLAUDINS; COHORT STUDIES; ENCEPHALITIS; FIBRINOGEN; HUMANS; MEMBRANE PROTEINS; NADPH OXIDASE; PHOSPHOPROTEINS; TIGHT JUNCTIONS;

EID: 84860218969     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000334916     Document Type: Article

References (16)

1. Richard E, Carrano A, Hoozemans JJ, van Horssen J, van Haastert ES, Eurelings LS, de Vries HE, Thal DR, Eikelenboom P, van Gool WA, Rozemuller AJ: Characteristics of dyshoric capillary cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2010; 69: 1158-1167.
2. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss- Cray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
3. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ: Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging 2000; 21: 39-47.
4. Rozemuller AJ, van Gool WA, Eikelenboom P: The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications. Curr Drug Targets CNS Neurol Disord 2005; 4: 223-233.
5. Carrano A, Hoozemans JJ, van der Vies SM, Rozemuller AJ, van Horssen J, de Vries HE: Ayloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 2011; 15: 1167-1178.
6. van Wetering S, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP, Collard JG, Hordijk PL: Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 2002; 115: 1837-1846.
7. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE: Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 2007; 21: 3666-3676.
8. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997; 68: 2061-2069.
9. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA: Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005; 93: 953-962.
10. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP: Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997; 68: 1870-1881.
11. Gonzalez-Velasquez FJ, Kotarek JA, Moss MA: Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem 2008; 107: 466-477.
12. Marco S, Skaper SD: Amyloid beta-peptide1- 42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett 2006; 401: 219-224.
13. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA: Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2010; 14: 1101-1112.
14. Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.
15. Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Schmidt AM, Chen JX, Yan SS: RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J 2010; 24: 1043-1055.
16. Hensley K: Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 2010; 21: 1-14.